المؤلفون: Rousseau A; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Tagliamento M; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France; Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genova, Italy., Auclin E; Medical Oncology Department, Hôpital Européen Georges Pompidou, AP-HP Centre, Université Paris Cité, Paris, France., Aldea M; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Frelaut M; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Levy A; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France; Paris-Saclay University, Orsay, France., Benitez JC; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Naltet C; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Lavaud P; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Botticella A; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Grecea M; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Chaput N; Laboratory of Immunomonitoring in Oncology, Gustave Roussy Cancer Campus, Villejuif, France; Paris-Saclay University, UFR Pharmacy, Orsay, France., Barlesi F; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Planchard D; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Besse B; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France; Paris-Saclay University, Orsay, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Mar; Vol. 182, pp. 107-114. Date of Electronic Publication: 2023 Jan 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy , Antineoplastic Agents, Immunological*/adverse effects, Humans ; Male ; Aged ; Female ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies

المؤلفون: Moreira A; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: aurelie.moreira@curie.fr., Masliah-Planchon J; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: julien.masliahplanchon@curie.fr., Callens C; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: celine.callens@curie.fr., Vacher S; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: sophie.vacher@curie.fr., Lecerf C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: charlotte.lecerf@curie.fr., Frelaut M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: maxime.frelaut@curie.fr., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: edith.borcoman@curie.fr., Torossian N; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: nouritza.torossian@curie.fr., Ricci F; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: francesco.ricci@curie.fr., Hescot S; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: segolene.hescot@curie.fr., Sablin MP; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: mariepaule.sablin@curie.fr., Tresca P; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: patricia.tresca@curie.fr., Loirat D; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: delphine.loirat@curie.fr., Melaabi S; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: samia.melaabi@curie.fr., Trabelsi-Grati O; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: olfa.trabelsigrati@curie.fr., Pierron G; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: gaelle.pierron@curie.fr., Gentien D; Department of Translational Research, Institut Curie, PSL Research University, Paris, France. Electronic address: david.gentien@curie.fr., Bernard V; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: Virginie.Bernard@curie.fr., Vincent Salomon A; Department of Pathology, Institut Curie, PSL Research University, Paris, France. Electronic address: anne.salomon@curie.fr., Servant N; INSERM U900, Institut Curie, Mines Paris Tech, Paris, France. Electronic address: nicolas.servant@curie.fr., Bieche I; Department of Genetics, Institut Curie, PSL Research University, Paris, France; INSERM U1016 Research Unit, Cochin Institute, Paris, France. Electronic address: ivan.bieche@curie.fr., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France; INSERM U900, Institut Curie, Mines Paris Tech, Paris, France; Paris-Saclay University, Paris, France. Electronic address: christophe.letourneau@curie.fr., Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France. Electronic address: maud.kamal@curie.fr.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Nov; Vol. 121, pp. 202-209. Date of Electronic Publication: 2019 Oct 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Algorithms* , Drug Approval*/methods , Drug Approval*/organization & administration, Antineoplastic Agents/*classification , Antineoplastic Agents/*therapeutic use , Molecular Targeted Therapy/*methods , Randomized Controlled Trials as Topic/*methods, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Clinical Trials, Phase II as Topic/methods ; Disease-Free Survival ; Evidence-Based Practice/standards ; Female ; France ; Humans ; Male ; Medical Oncology/organization & administration ; Medical Oncology/standards ; Middle Aged ; Precision Medicine/methods ; Prognosis ; Proof of Concept Study ; Research Design ; Retrospective Studies ; Societies, Medical/organization & administration ; Societies, Medical/standards ; Treatment Outcome ; Young Adult